European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478- Page

┌─────────────────────────────────────────────────────────────┐ │ Ph. Eur. Monograph 0478 │ └──────────────────────────────┬──────────────────────────────┘ │ ┌───────────────────────┼───────────────────────┐ ▼ ▼ ▼ Effervescent Dispersible Gastro-resistant ┌──────────────────────┐ ┌───────────────────┐ ┌───────────────────┐ │ Disintegrates

Monograph 0478 references several general chapters for routine testing: Ph. Eur. Chapter Key Requirement (General) Uncoated tablets: typically < 15 minutes in water at 37°C. Dissolution

Would you like a side-by-side comparison with the USP or JP tablet monographs as well? European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

“But manufacturing variability,” countered Luis, the production lead, “could spike scrap rates for legacy lines. Some suppliers can’t guarantee tighter granulation control without capital investment.”

This is arguably the most critical safety and efficacy test. It ensures that each tablet in a batch contains the active substance within a narrow range (typically 85–115% of the label claim). The test is performed according to General Chapter 2.9.40, using either content uniformity (individual assay of 10 tablets) or mass variation (weighing tablets for potent drugs). Failure here indicates poor manufacturing mixing or compression, leading to underdosing (ineffectiveness) or overdosing (toxicity). : Often called "hardness

If you need a deep dive into the for tests like the Uniformity of Dosage Units (2.9.40)?

: Modified-release formulations engineered to resist gastric fluid and release the API within the intestinal tract. ” countered Luis

: Often called "hardness," it measures the force needed to break the tablet.

Tablets must comply with standards for non-sterile preparations described in Ph. Eur. Chapter 5.1.4.